These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 22834289)

  • 1. [Prevention of stress-induced damage of the upper gastrointestinal mucosa in patients during early postoperative period].
    Nikoda VV; Bondarenko AV; Kiriushin DN; Liubivyĭ ED; Stamov VI
    Anesteziol Reanimatol; 2012; (2):51-5. PubMed ID: 22834289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral buffered esomeprazole is superior to i.v. pantoprazole for rapid rise of intragastric pH: a wireless pH metry analysis.
    Banerjee R; Reddy DN; Guda NM; Kalpala R; Mahurkar S; Darisetty S; Rao GV
    J Gastroenterol Hepatol; 2010 Jan; 25(1):43-7. PubMed ID: 19874444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of 24-hour intragastric acidity with morning dosing of immediate-release and delayed-release proton pump inhibitors in patients with GERD.
    Howden CW; Ballard ED; Koch FK; Gautille TC; Bagin RG
    J Clin Gastroenterol; 2009 Apr; 43(4):323-6. PubMed ID: 18758373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effective administration method of intravenous proton pump inhibitor: a novel testing using a BRAVO catheterless pH monitoring system.
    Kım KJ; Park MI; Park SJ; Cho SW; Moon W; Kim GM; Kim WM
    Turk J Gastroenterol; 2011 Dec; 22(6):575-81. PubMed ID: 22287401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety, pharmacokinetics, and pharmacodynamics of S-(-)-pantoprazole sodium injections after single and multiple intravenous doses in healthy Chinese subjects.
    Jiao HW; Sun LN; Li YQ; Yu L; Zhang HW; Wang MF; Yu LY; Yuan ZQ; Xie LJ; Chen J; Meng L; Zhang XH; Wang YQ
    Eur J Clin Pharmacol; 2018 Mar; 74(3):257-265. PubMed ID: 29167917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pantoprazole for the prevention of gastrointestinal bleeding in high-risk patients with acute coronary syndromes.
    Wu H; Jing Q; Wang J; Guo X
    J Crit Care; 2011 Aug; 26(4):434.e1-6. PubMed ID: 21273036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of preoperative intravenous pantoprazole in elective-surgery patients: a pilot study.
    Pisegna JR; Karlstadt RG; Norton JA; Fogel R; Oh DS; Jay Graepel G; Dorr MB
    Dig Dis Sci; 2009 May; 54(5):1041-9. PubMed ID: 18754096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of p.o. or i.v. proton pump inhibitors on 72-h intragastric pH in bleeding peptic ulcer.
    Javid G; Zargar SA; U-Saif R; Khan BA; Yatoo GN; Shah AH; Gulzar GM; Sodhi JS; Khan MA
    J Gastroenterol Hepatol; 2009 Jul; 24(7):1236-43. PubMed ID: 19682194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of proton pump inhibitors on gastric pH in patients exposed to severe stress.
    Lenz K; Buder R; Firlinger F; Lohr G; Voglmayr M
    Wien Klin Wochenschr; 2015 Jan; 127(1-2):51-6. PubMed ID: 25409944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimizing the intragastric pH as a supportive therapy in upper GI bleeding.
    Brunner G; Luna P; Hartmann M; Wurst W
    Yale J Biol Med; 1996; 69(3):225-31. PubMed ID: 9165691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of the Human Upper Gastrointestinal Contents in the Fasted State Under Hypo- and A-chlorhydric Gastric Conditions Under Conditions of Typical Drug - Drug Interaction Studies.
    Litou C; Vertzoni M; Goumas C; Vasdekis V; Xu W; Kesisoglou F; Reppas C
    Pharm Res; 2016 Jun; 33(6):1399-412. PubMed ID: 26975361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Standard and double-dose intravenous proton pump inhibitor injections for prevention of bleeding after endoscopic resection.
    Jung SW; Kim SY; Choe JW; Hyun JJ; Jung YK; Koo JS; Yim HJ; Lee SW
    J Gastroenterol Hepatol; 2017 Apr; 32(4):778-781. PubMed ID: 27637734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of gastric acid suppression with pantoprazole on the efficacy of calcium carbonate as a phosphate binder in haemodialysis patients.
    Cervelli MJ; Shaman A; Meade A; Carroll R; McDonald SP
    Nephrology (Carlton); 2012 Jul; 17(5):458-65. PubMed ID: 22471559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intermittent intravenous pantoprazole and continuous cimetidine infusion: effect on gastric pH control in critically ill patients at risk of developing stressed related mucosal disease.
    Tsai JJ; Lin HJ
    J Trauma; 2008 Nov; 65(5):1203-4. PubMed ID: 19001996
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of gastric acid suppression with pantoprazole on the efficacy of sevelamer hydrochloride as a phosphate binder in haemodialysis patients: a pilot study.
    Lai B; Cervelli MJ
    Nephrology (Carlton); 2012 May; 17(4):402-6. PubMed ID: 22329674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term, open-label trial: safety and efficacy of continuous maintenance treatment with pantoprazole for up to 15 years in severe acid-peptic disease.
    Brunner G; Athmann C; Schneider A
    Aliment Pharmacol Ther; 2012 Jul; 36(1):37-47. PubMed ID: 22531114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Famotidine versus pantoprazole for preventing bleeding in the upper gastrointestinal tract of critically ill patients receiving mechanical ventilation.
    Ojiako K; Shingala H; Schorr C; Gerber DR
    Am J Crit Care; 2008 Mar; 17(2):142-7. PubMed ID: 18310651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intermittent intravenous pantoprazole and continuous cimetidine infusion: effect on gastric pH control in critically ill patients at risk of developing stress-related mucosal disease.
    Somberg L; Morris J; Fantus R; Graepel J; Field BG; Lynn R; Karlstadt R
    J Trauma; 2008 May; 64(5):1202-10. PubMed ID: 18469642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Volume, distribution and acidity of gastric secretion on and off proton pump inhibitor treatment: a randomized double-blind controlled study in patients with gastro-esophageal reflux disease (GERD) and healthy subjects.
    Steingoetter A; Sauter M; Curcic J; Liu D; Menne D; Fried M; Fox M; Schwizer W
    BMC Gastroenterol; 2015 Sep; 15():111. PubMed ID: 26328588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of intravenous esomeprazole 40 mg and pantoprazole 40 mg on intragastric pH in healthy subjects. A prospective, open, randomised, two-way cross-over comparative study.
    Piccoli F; Ory G; Hadengue A; Beglinger C; Degen L
    Arzneimittelforschung; 2007; 57(10):654-8. PubMed ID: 18074759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.